Φορτώνει......
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
BACKGROUND: Cisplatin (DDP)-based chemotherapy is the mainstay of first-line therapy for lung cancer. However, their efficacy is often limited by the existence or development of chemoresistance. The aim of this study was to find and investigate the function of miRNAs in cisplatin (DDP)-resistant non...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Cell Int |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4828824/ https://ncbi.nlm.nih.gov/pubmed/27073334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0305-6 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|